Skip to main content
. 2015 May 8;10:67. doi: 10.1186/s13012-015-0258-5

Table 3.

Pre- and post-workshop comparisons of neonatal clinical outcomes

Intervention NICUs ( N = 2) Control NICUs ( N = 88) Intervention vs. control group difference
Outcomes Pre-WS n = 146 (%) Post-WS n = 148 (%) Unadjusted OR (95% CI) Adjusted OR (95% CI) Pre-WS n = 3,322 (%) Post-WS n = 2,912 (%) Unadjusted OR (95% CI) Adjusted OR (95% CI) DID in post- vs. pre-WS (95% CI)**
Mortality 15 (10.3) 5 (3.4) 0.31 (0.11, 0.86)* 0.30 (0.1, 0.89)* 207 (6.2) 147 (5.1) 0.80 (0.64, 0.99)* 0.75 (0.59, 0.95)* −5.71 (−11.6, 0.12)
RDS 80 (54.8) 90 (60.8) 1.28 (0.81,2.04) 1.55 (0.90, 2.68) 1,893/3,322 (57.0) 1,682/,2884 (58.3) 1.06 (0.96, 1.17) 1.05 (0.93, 1.18) 4.68 (−6.86, 16.2)
BPD 25/141 (17.7) 36/147 (24.5) 1.51 (0.85, 2.67) 1.66 (0.90, 3.07) 490/3,282 (14.9) 504/2,858 (17.6) 1.22 (1.07,1.40)* 1.23 (1.06, 1.44)* 4.05 (−5.51, 13.6)
Severe IVH 6 (4.1) 8 (5.4) 1.33 (0.45, 3.94) 1.38 (0.45, 4.27) 145/3,322 (4.4) 126/2,882 (4.4) 1.00 (0.78, 1.28) 1.0 (0.77, 1.30) 1.29 (−3.68, 6.26)
PVL 3/146 (2.1) 6/143 (4.2) 2.09 (0.51, 8.51) 2.09 (0.51, 8.51) 112/3,318 (3.4) 91/2,864 (3.2) 0.94 (0.71, 1.24) 1.0 (0.75, 1.34) 2.34 (−1.77, 6.45)
ROP 14/139 (10.1) 17/140 (12.1) 1.23 (0.58, 2.61) 1.50 (0.66, 3.41) 289/2,429 (11.9) 360/2,512 (14.3) 1.23 (1.05, 1.46)* 1.33 (1.11, 1.60)* 0.36 (−7.97, 7.24)
NEC 3 (2.1) 3 (2.0) 0.98 (0.19, 4.97) 1.11 (0.22, 5.72) 55/3,322 (1.7) 53/2,889 (1.8) 1.11 (0.76, 1.62) 1.01 (0.68, 1.51) −0.21 (−3.5, 3.09)
Early sepsis 3 (2.1) 2 (1.4) 0.65 (0.11, 3.97) 0.65 (0.11, 3.97) 88 (2.6) 92 (3.2) 1.20 (0.89, 1.61) 1.27 (0.94,1.73) −1.21 (−4.29, 1.86)
Late sepsis 7 (4.8) 6 (4.1) 0.84 (0.27, 2.56) 0.93 (0.30, 2.91) 168/3,313 (5.1) 172/2,880 (6.0) 1.19 (0.95, 1.48) 1.17 (0.93, 1.48) −1.64 (−6.48, 3.20)
PDA 47 (32.2) 45 (30.4) 0.92 (0.56, 1.51) 0.97 (0.57, 1.65) 1,286/3,322 (38.7) 1,109/2,884 (38.5) 0.99 (0.89, 1.10) 0.95 (0.85, 1.07) −1.53 (−12.4, 9.35)
Indomethacin 43 (29.5) 44 (29.7) 1.01 (0.61, 1.67) 1.01 (0.64, 1.86) 1,229 (37.0) 1,054 (36.2) 0.97 (0.87, 1.07) 0.93 (0.83, 1.05) 1.08 (−9.63, 11.8)
PDA ligation 13 (8.9) 7 (4.7) 0.51 (0.20, 1.31) 0.46 (0.17, 1.23) 208/3,322 (6.3) 185/2,865 (6.5) 1.03 (0.84, 1.27) 0.96 (0.77, 1.20) −4.37 (−10.3, 1.51)
Air leak 7 (4.8) 4 (2.7) 0.55 (0.16, 1.93) 0.66 (0.17, 2.22) 88/3,322 (2.7) 93/2,880 (3.2) 1.23 (0.91, 1.65) 1.22 (0.90, 1.66) −2.67 (−7.09, 1.75)
PPHN 11 (7.5) 15 (10.1) 1.38 (0.61, 3.12) 1.33 (0.57, 3.17) 132/3,322 (4.0) 152/2,872 (5.3) 1.35 (1.06, 1.71)* 1.39 (1.09,1.79)* 1.28 (−5.28, 7.85)

Variables with missing data are indicated by the denominators showing the numbers of the assessed neonates. Covariates included in the multiple logistic regression models were gender, gestational age, Apgar score < 7 at 5 minutes, cesarean section, antenatal steroids use, maternal hypertension, chorioamnionitis, and outborn.

Pre-WS: before the workshops; Post-WS: after the workshops. OR odds ratio, 95% CI 95% confidence interval, RDS respiratory distress syndrome, BPD bronchopulmonary dysplasia, IVH intraventricular hemorrhage, PVL periventricular leukomalacia, ROP retinopathy of prematurity, NEC necrotizing enterocolitis, PDA patent ductus arteriosus, PPHN persistent pulmonary hypertension.

*Statistically significant at the 5% probability level; **DID: The difference in differences of neonatal outcomes (percentage points) = differences (%) between the post- and pre-WS for the intervention NICUs − differences (%) between the post- and pre-WS for the control NICUs, estimated using a probit model.